Skip to main content

Table 3 Several metabolic and inflammatory parameters observed in the whole group of DTC subjects and in controls.

From: Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study

 

DTC subjects

Control subjects

Significance

Glucose (mmol/L)

4.7 ± 0.1

4.9 ± 0.1

ns

Insulin (mU/L)

8.5 ± 0.5

7.7 ± 0.6

P = 0.05

HOMA-IR [(mU × mmol)/22.5]

1.85 ± 0.13

1.74 ± 0.17

ns

HbA1c (%)

5.7 ± 0.1

5.7 ± 0.1

ns

Cholesterol (mmol/L)

5.36 ± 0.10

5.51 ± 0.11

ns

HDL-cholesterol (mmol/L)

1.71 ± 0.04

2.04 ± 0.09

P = 0.01

LDL-cholesterol (mmol/L)

3.11 ± 0.09

2.93 ± 0.11

ns

Triglycerides (mmol/L)

1.26 ± 0.06

1.21 ± 0.07

ns

CRP (mg/l)

4.4 ± 0.4

4.2 ± 0.3

ns

Fibrinogen (g/L)

355 ± 6

363 ± 10

ns

  1. Data are reported as mean ± SEM.